ADTX Stock Analysis: Buy, Sell, or Hold?
ADTX - Aditxt, Inc. Common Stock
$0.79
-0.02 (-2.58%)
▼
5d:
-26.94%
30d:
+72.59%
90d:
-29.54%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Get Alerted When ADTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ADTX is down 26.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ADTX is down 26.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADTX is currently trading at $0.79, which is considered fair relative to its 30-day fair value range of $0.30 to $1.98.
Technical Outlook: Technically, ADTX is in a strong downtrend. The price is currently testing key support at $0.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+7630.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADTX is in a strong downtrend. The price is currently testing key support at $0.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+7630.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.30 -
$1.98
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 7630.3% below Wall St target ($61.00)
- WARNING: Recommendation downgraded due to -26.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.30 -
$1.98
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.78
Resistance Level
$1.60
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.37
Wall Street Target
$61.00
(+7630.3%)
Revenue Growth (YoY)
-89.1%
Share & Embed Analysis
Last updated: March 30, 2026 6:10 PM ET
Data refreshes hourly during market hours. Next update: 7:10 PM
Data refreshes hourly during market hours. Next update: 7:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brian Michael Brady
SELL
2025-12-17
Corinne Pankovcin
SELL
2025-11-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 48 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 48 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 49 HOLD |
